Assessment of buccal aerosolized midazolam for pediatric conscious sedation
Article first published online: 20 DEC 2013
© 2013 Wiley Publishing Asia Pty Ltd
Journal of Investigative and Clinical Dentistry
Volume 6, Issue 1, pages 40–44, February 2015
How to Cite
Chopra, R. and Marwaha, M. (2015), Assessment of buccal aerosolized midazolam for pediatric conscious sedation. Journal of Investigative and Clinical Dentistry, 6: 40–44. doi: 10.1111/jicd.12062
- Issue published online: 9 FEB 2015
- Article first published online: 20 DEC 2013
- Manuscript Accepted: 30 APR 2013
- Manuscript Received: 20 FEB 2013
- buccal midazolam;
- conscious sedation;
- pediatric dentistry
To assess the acceptance and efficacy of aerosolized midazolam through buccal mucosa for conscious sedation.
Thirty-five children aged 2–6 years with Grade I and II Frankl behavior rating scale were selected for various dental procedures under local anesthesia. Initially behavior-shaping procedures were used and Houpt behavior scoring was recorded. Thereafter, midazolam was administered using a spray through buccal mucosa and scores for acceptance of drug and behavior after sedation were recorded. The data were compiled and a Wilcoxon signed ranks test was used to assess the difference in behavior before and after the sedation.
Eighty-three percent of the patients accepted the drug without any complaint. A statistically significant improvement was seen in the Houpt scores before and after drug administration (P < 0.001).
Buccal aerosolized midazolam can be used successfully for pediatric conscious sedation.